Barinthus Biotherapeutics
BRNS
$2.43
Share price
9.45%
Change (1 day)
2.53%
Change (1 year)
Categories
P/S ratio for Barinthus Biotherapeutics (BRNS)
P/S ratio as of May 2024 (TTM): 118
According to Barinthus Biotherapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 118.455. At the end of 2023 the company had a P/S ratio of 177.
P/S ratio history for Barinthus Biotherapeutics from 2021 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 177 | 8950.01% |
| 2022 | 1.96 | -99.87% |
| 2021 | > 1000 |